Drugs Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
Current Valuation | Efficiency | Market Risk | Exp Return | ||||
---|---|---|---|---|---|---|---|
1 | AMGN | Amgen Inc | (0.15) | 1.69 | (0.25) | ||
2 | CAH | Cardinal Health | 0.10 | 1.53 | 0.15 | ||
3 | CTLT | Catalent | 0.00 | 0.61 | 0.00 | ||
4 | TFX | Teleflex Incorporated | (0.16) | 2.23 | (0.36) | ||
5 | MMSI | Merit Medical Systems | 0.10 | 1.20 | 0.12 | ||
6 | ALVO | Alvotech | 0.01 | 1.72 | 0.01 | ||
7 | HCM | HUTCHMED DRC | 0.04 | 3.23 | 0.14 | ||
8 | TNDM | Tandem Diabetes Care | (0.15) | 3.17 | (0.48) | ||
9 | ATEC | Alphatec Holdings | 0.13 | 6.38 | 0.82 | ||
10 | SNDA | Sonida Senior Living | (0.02) | 3.09 | (0.06) | ||
11 | AVDL | Avadel Pharmaceuticals PLC | (0.09) | 4.34 | (0.39) | ||
12 | ESPR | Esperion Therapeutics | 0.14 | 4.61 | 0.62 | ||
13 | CTKB | Cytek Biosciences | 0.06 | 5.78 | 0.34 | ||
14 | TMCI | Treace Medical Concepts | 0.12 | 5.64 | 0.66 | ||
15 | AQST | Aquestive Therapeutics | 0.07 | 4.26 | 0.30 | ||
16 | VMD | Viemed Healthcare | 0.10 | 2.04 | 0.21 | ||
17 | AHG | Akso Health Group | 0.00 | 8.31 | 0.00 | ||
18 | JYNT | The Joint Corp | 0.02 | 2.94 | 0.07 | ||
19 | XTNT | Xtant Medical Holdings | (0.15) | 5.57 | (0.81) | ||
20 | LNSR | LENSAR Inc | 0.18 | 4.97 | 0.91 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.